Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
106.60
+1.10 (1.04%)
At close: Sep 3, 2026
| Market Cap | 24.62B -23.2% |
| Revenue (ttm) | 15.57B +30.2% |
| Net Income | 1.46B +74.1% |
| EPS | 6.31 +74.1% |
| Shares Out | 231.00M |
| PE Ratio | 16.90 |
| Forward PE | n/a |
| Dividend | 2.10 (1.97%) |
| Ex-Dividend Date | Nov 17, 2025 |
| Volume | 88,192 |
| Open | 105.70 |
| Previous Close | 105.50 |
| Day's Range | 105.00 - 107.40 |
| 52-Week Range | 96.00 - 140.80 |
| Beta | -0.10 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |